Free Newsletter
Vaccine makers to produce record amount of flu jab
The five key vaccine makers say they plan to produce a record 143 million doses of flu vaccine for the U.S. market next season, which should be enough to satisfy demand. Manufacturers delivered 140 million doses for the last flu season, most of which were useless against the strains that were actually in circulation. Each year some 200,000 people in the U.S. are hospitalized for the flu, and 36,000 people die from it.
- read the report from Newsday
Related Articles:
Flu jab missing the mark in seasonal campaign
Vaccines not useful for seasonal flu
Universal flu vaccine shows early promise
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


